Table 3.
Eight breast cancer cell lines with inconsistent annotations on the status of primary markers.
| Cell lines | ER | PR | HER2 | Subtype | Reference |
|---|---|---|---|---|---|
| HCC1007 | + | - | - | LA | 5 |
| HCC1007 | + | - | + | LB | 8 |
| HCC1007 | - | - | + | H | 12 |
| HCC1419 | + | - | + | LB | 1 |
| HCC1419 | - | - | + | H | 8, 12 |
| HCC1500 | + | + | - | LA | 1, 8, 12 |
| HCC1500 | - | - | - | TNB | 5 |
| HCC2185 | - | - | - | TNA | 5, 8 |
| HCC2185 | - | - | + | H | 12 |
| SUM52PE | + | - | + | LB | 8 |
| SUM52PE | + | - | - | LA | 1, 5, 6 |
| SUM44PE | + | + | + | LB | 8 |
| SUM44PE | + | +/- | - | LA | 1, 5, 6 |
| EVSA-T | - | - | + | H | 6 |
| EVSA-T | - | + | - | LA | 1 |
| MPE600 | + | - | - | LA | 5 |
| MPE600 | + | - | + | LB | 1, 6 |
We categorise these cell lines into luminal A (LA), luminal B (LB), HER2 positive (H), Triple negative A (TNA) and Triple negative B (TNB) according to the status of ER, PR and HER2. References where such information is derived are provided in the 'Reference' column.